These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8725543)

  • 41. [Value of positron emission tomography with 18-fluorodeoxyglucose (FDG-PET) in early detection of residual tumor in oro-pharyngeal-laryngeal carcinoma].
    Haenggeli CA; Dulguerov P; Slosman D; Becker M; Bang P; Allal A; Guyot JP; Lehmann W
    Schweiz Med Wochenschr Suppl; 2000; 116():8S-11S. PubMed ID: 10780061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 18F-FDG PET for retropharyngeal lymph node metastasis in oropharyngeal and hypopharyngeal cancers: impact on diagnosis and prediction analysis.
    Chan SC; Lin CY; Ng SH; Chang JT; Wang HM; Liao CT; Lo CW; Yen TC
    Nucl Med Commun; 2010 Mar; 31(3):260-5. PubMed ID: 20072075
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.
    Leblanc E; Gauthier H; Querleu D; Ferron G; Zerdoud S; Morice P; Uzan C; Lumbroso S; Lecuru F; Bats AS; Ghazzar N; Bannier M; Houvenaeghel G; Brenot-Rossi I; Narducci F
    Ann Surg Oncol; 2011 Aug; 18(8):2302-9. PubMed ID: 21347790
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Imaging in head and neck cancers].
    Iannessi A; Ouvrier MJ; Thariat J; Marcy PY
    Bull Cancer; 2014 May; 101(5):469-80. PubMed ID: 24886898
    [TBL] [Abstract][Full Text] [Related]  

  • 45. F-18 fluoro-D-glucose (FDG)-positron emission tomography (PET)/computed tomography (CT) in planning of surgery and sentinel lymph node screening in vulvar cancers.
    Dolanbay M; Ozcelik B; Abdulrezzak U; Serin IS; Kutuk MS; Uludag S
    Arch Gynecol Obstet; 2016 Jun; 293(6):1319-24. PubMed ID: 26498604
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
    Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
    J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prediction of ultrasound guided fine needle aspiration cytology results by FDG PET-CT for lymph node metastases in head and neck squamous cell carcinoma patients.
    Peltenburg B; de Keizer B; Dankbaar JW; de Boer M; Willems SM; Philippens MEP; Terhaard CHJ; de Bree R
    Acta Oncol; 2018 Dec; 57(12):1687-1692. PubMed ID: 30489180
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Utility of ¹⁸F-FDG PET/CT in identifying penile squamous cell carcinoma metastatic lymph nodes.
    Rosevear HM; Williams H; Collins M; Lightfoot AJ; Coleman T; Brown JA
    Urol Oncol; 2012 Sep; 30(5):723-6. PubMed ID: 21396850
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Analysis of cervical lymph node metastasis of oropharyngeal carcinoma in relation to extent of the primary tumor].
    Pfreundner L; Pahnke J; Wameling S
    Laryngorhinootologie; 1996 Apr; 75(4):223-30. PubMed ID: 8688128
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling.
    Steinert HC; Hauser M; Allemann F; Engel H; Berthold T; von Schulthess GK; Weder W
    Radiology; 1997 Feb; 202(2):441-6. PubMed ID: 9015071
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET.
    Choi JY; Lee KH; Shim YM; Lee KS; Kim JJ; Kim SE; Kim BT
    J Nucl Med; 2000 May; 41(5):808-15. PubMed ID: 10809196
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer.
    Driscoll DO; Halpenny D; Johnston C; Sheehy N; Keogan M
    Abdom Imaging; 2015 Jan; 40(1):127-33. PubMed ID: 25015401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lymph node staging in extracranial head and neck cancer with FDG PET--appropriate uptake period and size-dependence of the results.
    Brink I; Klenzner T; Krause T; Mix M; Ross UH; Moser E; Nitzsche EU
    Nuklearmedizin; 2002 Apr; 41(2):108-13. PubMed ID: 11989297
    [TBL] [Abstract][Full Text] [Related]  

  • 54. FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.
    Swinnen G; Maes A; Pottel H; Vanneste A; Billiet I; Lesage K; Werbrouck P
    Eur Urol; 2010 Apr; 57(4):641-7. PubMed ID: 19477579
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings.
    Konishi J; Yamazaki K; Tsukamoto E; Tamaki N; Onodera Y; Otake T; Morikawa T; Kinoshita I; Dosaka-Akita H; Nishimura M
    Respiration; 2003; 70(5):500-6. PubMed ID: 14665776
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 18F-FDG-PET/CT for the assessment of the contralateral neck in patients with head and neck squamous cell carcinoma.
    Kastrinidis N; Kuhn FP; Hany TF; Ahmad N; Huber GF; Haerle SK
    Laryngoscope; 2013 May; 123(5):1210-5. PubMed ID: 23426442
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
    Kim JW; Oh JS; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
    Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Imaging Anatomy of Waldeyer's Ring and PET/CT and MRI Findings of Oropharyngeal Non-Hodgkin's Lymphoma.
    Zhang CX; Liang L; Zhang B; Chen WB; Liu HJ; Liu CL; Zhou ZG; Liang CH; Zhang SX
    Asian Pac J Cancer Prev; 2015; 16(8):3333-8. PubMed ID: 25921140
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Contrast-enhanced ¹⁸F-FDG-PET/CT for the assessment of necrotic lymph node metastases.
    Haerle SK; Strobel K; Ahmad N; Soltermann A; Schmid DT; Stoeckli SJ
    Head Neck; 2011 Mar; 33(3):324-9. PubMed ID: 20652890
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis.
    Kyzas PA; Evangelou E; Denaxa-Kyza D; Ioannidis JP
    J Natl Cancer Inst; 2008 May; 100(10):712-20. PubMed ID: 18477804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.